Charles Lucas
About
In The Last Decade
Charles Lucas
22 papers receiving 269 citations
Peers
Comparison fields: 5 of 70
- Emergency Medicine 162
- Surgery 113
- Public Health, Environmental and Occupational Health 65
- Pulmonary and Respiratory Medicine 35
- Safety, Risk, Reliability and Quality 21
Countries citing papers authored by Charles Lucas
This map shows the geographic impact of Charles Lucas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Lucas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Lucas more than expected).
Fields of papers citing papers by Charles Lucas
This network shows the impact of papers produced by Charles Lucas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Lucas. The network helps show where Charles Lucas may publish in the future.
Co-authorship network of co-authors of Charles Lucas
This figure shows the co-authorship network connecting the top 25 collaborators of Charles Lucas. A scholar is included among the top collaborators of Charles Lucas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Lucas. Charles Lucas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | Preliminary data on feasibility of vinflunine (VFL)-based combinations as 1st line in CDDP-unfit patients (pts) with advanced urothelial carcinoma (UC): VFL/gemcitabine vs. VFL/CBDCA in a randomised international phase II trial (JASINT1) | 3 |
| 5 | 2 | |
| 6 | 7 | |
| 7 | 12 | |
| 8 | 1 | |
| 9 | The infernal Quixote : a tale of the day (1801) | 1 |
| 10 | 5 | |
| 11 | The Infernal Quixote | 2 |
| 12 | 156 | |
| 13 | 2 | |
| 14 | 3 | |
| 15 | [Tolerance and clinical and biological responses during the first 6 months of treatment with 1-month sustained release LHRH agonists leuprolerin and triptolerin in patients with metastatic prostate cancer]. | 13 |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 44 | |
| 19 | 0 | |
| 20 | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.